ID

28043

Beschrijving

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Past medical conditions

Trefwoorden

Versies (3)

1. 27-08-17 27-08-17 -
2. 23-10-17 23-10-17 -
3. 12-12-17 12-12-17 -

Houder van rechten

GlaxoSmithKline

Geüploaded op

12 december 2017

DOI

Voor een aanvraag inloggen.

Licentie